Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 10 studies | 26% ± 7% | |
oligodendrocyte | 5 studies | 19% ± 4% | |
epithelial cell | 4 studies | 24% ± 6% | |
astrocyte | 4 studies | 20% ± 4% | |
glutamatergic neuron | 4 studies | 42% ± 19% | |
ciliated cell | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 36% ± 11% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 1% | |
interneuron | 3 studies | 26% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1032.00 | 1445 / 1445 | 100% | 16.71 | 183 / 183 |
liver | 100% | 678.81 | 226 / 226 | 100% | 13.30 | 406 / 406 |
brain | 100% | 1516.41 | 2641 / 2642 | 100% | 19.34 | 705 / 705 |
intestine | 100% | 857.68 | 966 / 966 | 100% | 21.51 | 526 / 527 |
kidney | 100% | 741.20 | 89 / 89 | 100% | 16.16 | 899 / 901 |
breast | 100% | 696.51 | 459 / 459 | 100% | 13.74 | 1115 / 1118 |
stomach | 100% | 717.35 | 358 / 359 | 100% | 20.46 | 286 / 286 |
lung | 99% | 995.21 | 575 / 578 | 100% | 15.11 | 1155 / 1155 |
skin | 100% | 965.70 | 1807 / 1809 | 100% | 16.65 | 470 / 472 |
prostate | 100% | 729.42 | 244 / 245 | 100% | 15.86 | 501 / 502 |
thymus | 100% | 664.21 | 651 / 653 | 100% | 16.68 | 603 / 605 |
adrenal gland | 100% | 1104.45 | 258 / 258 | 99% | 29.00 | 228 / 230 |
bladder | 100% | 841.33 | 21 / 21 | 99% | 16.17 | 499 / 504 |
ovary | 100% | 645.41 | 180 / 180 | 99% | 9.73 | 425 / 430 |
uterus | 100% | 689.84 | 170 / 170 | 98% | 13.89 | 450 / 459 |
pancreas | 97% | 458.15 | 319 / 328 | 100% | 13.63 | 178 / 178 |
adipose | 100% | 676.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.76 | 29 / 29 |
muscle | 100% | 1847.78 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 504.77 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.40 | 1 / 1 |
blood vessel | 100% | 999.98 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 9.64 | 79 / 80 |
heart | 96% | 812.40 | 830 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 22% | 232.30 | 206 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005515 | Molecular function | protein binding |
Gene name | SPRYD7 |
Protein name | SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein) (CLL deletion region gene 6 protein) |
Synonyms | C13orf1 CLLD6 |
Description | |
Accessions | ENST00000378195.6 [Q5W111-2] ENST00000361840.8 [Q5W111-1] Q5W111 |